Are patients with lung cystic fibrosis at increased risk of severe and fatal COVID-19? Interleukin 6 as a predictor of COVID-19 outcomes

被引：10
|
作者：
Marcinkiewicz, Janusz [1 ]
Mazurek, Henryk [2 ]
Majka, Grzegorz [1 ]
Chain, Benjamin [3 ]
机构：
[1] Jagiellonian Univ Med Coll, Fac Med, Chair Immunol, Ul Czysta 18, PL-31121 Krakow, Poland
[2] Inst TB & Lung Disorders, Dept Pneumonol & Cyst Fibrosis, Rabka Zdroj, Poland
[3] UCL, Div Infect & Immun, London, England
来源：
POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ | 2020年 / 130卷 / 10期
关键词：
PEOPLE;
D O I：
10.20452/pamw.15630
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：919 / 920
页数：2
相关论文
共 50 条
  • [31] Is smoking a risk factor for severe outcomes in COVID-19?
    Abdenneji, S.
    Fekih, W.
    Ben Krayen, I.
    El Ghoul, J.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [32] The clinical characteristics and risk factors for severe COVID-19 in patients with COVID-19 and tuberculosis coinfection
    Wang, Yang
    Chen, Yanping
    Gu, Lina
    Lou, Lixin
    Zhang, Jian
    Zhang, Kaiyu
    FRONTIERS IN MICROBIOLOGY, 2022, 13
  • [33] Impact of COVID-19 on people with cystic fibrosis
    Colombo, Carla
    Burgel, Pierre-Regis
    Gartner, Silvia
    van Koningsbruggen-Rietschel, Silke
    Naehrlich, Lutz
    Sermet-Gaudelus, Isabelle
    Southern, Kevin W.
    LANCET RESPIRATORY MEDICINE, 2020, 8 (05): : E35 - E36
  • [34] Cystic fibrosis telemedicine in the era of COVID-19
    Rad, Elika J.
    Mirza, Alicia A.
    Chhatwani, Laveena
    Purington, Natasha
    Mohabir, Paul K.
    JAMIA OPEN, 2022, 5 (01)
  • [35] Severe and fatal forms of COVID-19 in children
    Oualha, M.
    Bendavid, M.
    Berteloot, L.
    Corsia, A.
    Lesage, F.
    Vedrenne, M.
    Salvador, E.
    Grimaud, M.
    Chareyre, J.
    de Marcellus, C.
    Dupic, L.
    de Saint Blanquat, L.
    Heilbronner, C.
    Drummond, D.
    Castelle, M.
    Berthaud, R.
    Angoulvant, F.
    Toubiana, J.
    Pinhas, Y.
    Frange, P.
    Cheron, G.
    Fourgeaud, J.
    Moulin, F.
    Renolleau, S.
    ARCHIVES DE PEDIATRIE, 2020, 27 (05): : 235 - 238
  • [36] Cystic fibrosis and COVID-19: Care considerations
    Mirza, Alicia A.
    Rad, Elika J.
    Mohabir, Paul K.
    RESPIRATORY MEDICINE CASE REPORTS, 2020, 31
  • [37] COVID-19 Risk and Outcomes for Patients With Cancer
    不详
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 326 (24): : 2459 - 2459
  • [38] Incidence and Risk Factors for Severe Outcomes in Pediatric Patients With COVID-19
    Ho, Milan
    Most, Zachary M.
    Perl, Trish M.
    Diaz, Marlon I.
    Casazza, Julia A.
    Saleh, Sameh
    Pickering, Madison
    Radunsky, Alexander P.
    Hanna, John J.
    Thakur, Bhaskar
    Lehmann, Christoph U.
    Medford, Richard J.
    Turer, Robert W.
    HOSPITAL PEDIATRICS, 2023, 13 (05) : 450 - 458
  • [39] Treatment of severe covid-19 with interleukin 6 receptor inhibition
    Rajasundaram, Skanda
    Burgess, Stephen
    Gill, Dipender
    BMJ MEDICINE, 2022, 1 (01):
  • [40] Hyperglycemia in Severe and Critical COVID-19 Patients: Risk Factors and Outcomes
    Le, Viet Tran
    Ha, Quoc Hung
    Tran, Minh Triet
    Le, Ngoc Trong
    Le, Van Tuyen
    Le, Minh Khoi
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (08)
12345